2 More Studies Link Bayer Heart Drug To Deaths

ATLANTA - Heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, two more U.S. studies have found, renewing the claims that the drug is dangerous.

Bayer AG stopped selling the drug last fall, after a Canadian study was halted because of deaths among patients taking Trasylol.

But the new research reignited controversy over Trasylol, which was on the market for 14 years and used by doctors to treat hundreds of thousands of heart bypass patients each year.

http://www.msnbc.msn.com/id/23259981/

More on This

Migraines May Signal Higher Risk of Cardiovascular Disease

Are You Heart Smart? Heart Attacks Different in Women Than in Men

Are You at Risk of a Heart Attack? Why Women Often Don’t Know

Does Your Heart Health Need a Checkup?

Tags:

• Heart Attack